Glenview Capital Management
GLENVIEW CAPITAL MANAGEMENT, LLC · NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗Activist Investor
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$5.63B2026 Q3+ $498.4M options (notional, not included)
Positions140
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.55.8%
Portfolio Composition
Sector Allocation
Top 25 positions; names without a sector (ETFs, unresolved CUSIPs) sit in the "Unclassified" slice. Totals 100%.
Option Positions
PUT 4.2%CALL 0.0%
| Symbol | Company | Type | Notional value (underlying shares) For option lines a 13F reports the market value of the shares the contracts are written on. It is not the premium the fund paid or the value of the options themselves, so it is not added to the fund's assets. | % Port. |
|---|---|---|---|---|
| IWM | Ishares Tr | Put | $255.7M | 4.17% |
13F reports options at notional share-equivalent value; premium cost and strikes are not disclosed.
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| D.E. Shaw & Co | 11.8% | BSX, EAT, BURL, CI, CVS, CVNA, DHR, DOCU +49 |
| Two Sigma Investments | 10.7% | BSX, CI, CVS, CDNS, CVNA, DHR, DOCU, HUM +52 |
| Alyeska Investment Group | 10.5% | BSX, EAT, BRKR, BURL, CVS, CVNA, DHR, HUM +28 |
| Bridgewater Associates (Ray Dalio) | 10.4% | BSX, CI, CVS, DHR, HUM, KLAC, LLY, MRVL +34 |
| Capital Research Global Investors | 10.4% | CI, CVS, CVNA, DHR, HUM, KLAC, LLY, MRVL +18 |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.